Iain Kilty - Concepedia

Author

Iain Kilty

Pfizer (United States)

Also Known As

I C Kilty, I Kilty, I. C. Kilty, I. Kilty, I.C. Kilty, IAIN C. KILTY, Iain C. Kilty, Iain Kilty, Kilty, I., Kilty, Iain

Publications

2.9K

Citations

H-Index

Concepts

All Affiliations

Pfizer (United States)Pfizer (United Kingdom)Imperial College London University of Leicester University of Nottingham

About

Iain Kilty is an author at Pfizer (United States) specializing in medicine, inflammation, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	14	1.1K
2	Biochemistry	3	3	180
3	Engineering	2	2	120
4	Natural Sciences	2	2	158
5	Allergy	2	2	78

Iain Kilty

Publications

2.5K

Citations

H-Index

Page 1

	Year	Citations
Cigarette smoke induces proinflammatory cytokine release by activation of NF-κB and posttranslational modifications of histone deacetylase in macrophages Se‐Ran Yang, Asiya Seema Chida, Mark R. Bauter, American Journal of Physiology-Lung Cellular and Molecular Physiology Inflammatory Lung DiseaseLung InflammationImmunologyImmune RegulationOxidative Stress	2006	488
Oxidative stress and cigarette smoke alter chromatin remodeling but differentially regulate NF‐κB activation and proinflammatory cytokine release in alveolar epithelial cells Fiona M. Moodie, John A. Marwick, Charlotte S. Anderson, The FASEB Journal	2004	325
PF-06651600, a Dual JAK3/TEC Family Kinase Inhibitor Hua Xu, Michael I. Jesson, Uthpala Seneviratne, ACS Chemical Biology	2019	152
Discovery of Clinical Candidate 1-{[(2 <i>S</i> ,3 <i>S</i> ,4 <i>S</i> )-3-Ethyl-4-fluoro-5-oxopyrrolidin-2-yl]methoxy}-7-methoxyisoquinoline-6-carboxamide (PF-06650833), a Potent, Selective Inhibitor of Interleukin-1 Receptor Associated Kinase 4 (IRAK4), by Fragment-Based Drug Design Katherine L. Lee, Catherine M. Ambler, David R. Anderson, Journal of Medicinal Chemistry	2017	138
Defective bacterial phagocytosis is associated with dysfunctional mitochondria in COPD macrophages Kylie Belchamber, Richa Singh, Craig Batista, European Respiratory Journal	2019	131
Design and Synthesis of Inhaled p38 Inhibitors for the Treatment of Chronic Obstructive Pulmonary Disease David S. Millan, Mark E. Bunnage, Jane L. Burrows, Journal of Medicinal Chemistry Pharmaceutical ScienceP38 InhibitorsPharmacotherapyLead SeriesMedicinal Chemistry	2011	94
The Interleukin‐1 Receptor–Associated Kinase 4 Inhibitor PF‐06650833 Blocks Inflammation in Preclinical Models of Rheumatic Disease and in Humans Enrolled in a Randomized Clinical Trial Aaron Winkler, Weiyong Sun, Saurav De, Arthritis & Rheumatology	2021	86
Improved image analysis workflow for 2‐D gels enables large‐scale 2‐D gel‐based proteomics studies – COPD biomarker discovery study Julia E. Bandow, John D. Baker, Matthias Berth, PROTEOMICS EngineeringMolecular BiologyPathologyImproved Image AnalysisProteomic Technology	2008	80
Effect of JAK Inhibitors on Release of CXCL9, CXCL10 and CXCL11 from Human Airway Epithelial Cells Peter Fenwick, Patricia Macedo, Iain Kilty, PLoS ONE	2015	67
Opsonic Phagocytosis in Chronic Obstructive Pulmonary Disease Is Enhanced by Nrf2 Agonists Martin A. Bewley, Richard C. Budd, Eilíse M. Ryan, American Journal of Respiratory and Critical Care Medicine	2018	67

Page 1